Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy
Stopped low enrollment and remaining oncologist workload
Conditions
- Non Small Cell Lung Cancer
Interventions
Sponsor
Muhammad Furqan
Collaborators